Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study,BJU International

当前位置： X-MOL 学术 › BJU Int. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Incidence of testicular cancer in trans women using gender-affirming hormonal treatment: a nationwide cohort study
BJU International ( IF 3.7 ) Pub Date : 2021-08-14 , DOI: 10.1111/bju.15575
Iris de Nie _{1,

2} , Chantal M Wiepjes _{1,

2} , Christel J M de Blok _{1,

2} , R Jeroen A van Moorselaar ₃ , Garry L S Pigot _{2,

3} , Tim M van der Sluis ₃ , Ellis Barbé ₄ , Patrick van der Voorn ₄ , Norah M van Mello _{2,

5} , Judith Huirne ₅ , Martin den Heijer _{1,

2}

Affiliation

To assess the incidence of testicular cancer in trans women (male sex assigned at birth, female gender identity) using gender-affirming hormonal treatment.

中文翻译：